LEADERSHIP TEAM

LEADERSHIP TEAM PROFILES

Our leadership team is proud to uphold the core values, vision and mission for Alexium associates and our investors.

WILLIAM "BILLY" BLACKBURN

Chief Executive Officer

Billy Blackburn joined Alexium with 25 years’ experience and a successful record of product commercialization and driving profitable revenue growth. He is a graduate of the University of South Carolina business school. He specializes in driving growth in businesses with technical offerings. He has led the startup, growth and sale of a specialty chemical business focused on sustainability and high-purity chemistry. He has led companies through successful turnarounds via positive culture changes that shifted organizational focus to customers and world class service.

BOARD OF DIRECTORS

RANDALL LANE

Non-Executive Director

Randall Lane has had an exceptional career in research, manufacturing, start-ups and product commercialization including 25 years of senior management positions in the chemical and medical device industries.

Specifically, he has served as CEO/CSO at CAVU group, comprised of Microtek, American Thermal Instruments and Latent Heat Solutions. Mr. Lane has also served on several Boards in the private sector.

SIMON MOORE

Non-Executive Director

Simon Moore, a Senior Partner of Colinton Capital Partners, has been appointed as non-executive director. Mr. Moore has over 20 years of experience in senior private equity roles including previously acting as Managing Director and Global Partner of the Carlyle Group. He currently serves on several boards, including in the role of NED at Dimeo Cleaning Services and NED at AMS Group.

DR PAUL STENSON

Non-Executive Director

Dr. Paul Stenson BSc (Science), PhD (Chemistry) has had a distinguished career with the research, development, manufacture, and commercialization of new materials. Dr. Stenson is currently President and CEO of StanChem Inc., comprising of two companies – StanChem Polymers, and Albi Protective Coatings. Dr Stenson has over 20 years of experience in senior management positions in the polymer and chemicals industry. Dr. Stenson is also the chairman of TopChem Pharmaceuticals (Ireland) which is a manufacturer of active pharmaceutical ingredients.

MARTYN STRICKLAND

Non-Executive Director

Martyn Strickland is an Operating Partner with Colinton Capital Partners. Martyn joined the firm in June 2017 and represents Colinton Capital Partners on AMSG, Dimeo, Alexium and Clear Dynamics investments.

Prior to joining Colinton Capital Partners, Martyn was a Senior Partner at Deloitte, where he led their middle-market strategy and the Operational Restructuring and CRO services divisions within the Financial Advisory business. In his time as Managing Director with 333 Consulting, he provided leadership, as Principal with A.T.Kearney and as Operating Executive with Cadbury Schweppes.

Martyn has an MBA from the Melbourne Business School and a degree in Mechanical Engineering from the University of Melbourne.

JAMES WILLIAMSON

Non-Executive Director

James Williamson has over 28 years of experience in financial markets and is the Co-Founder and Chief Investment Officer of Wentworth Williamson Management, a substantial shareholder of Alexium International Group Limited. Founded in 2013, Wentworth Williamson Management is a private Australian-based value fund manager with both equity and private credit funds. Prior to Wentworth Williamson, Mr Williamson worked for Allan Gray Australia and prior to that he was Portfolio Manager of the Investec Australian Equity Fund.

James has a Bachelor of Commerce, a Graduate Diploma of the Securities Institute of Australia and is a Senior Associate of FINSIA.